Pharmacological Effects of Caffeic Acid and Its Derivatives in Cancer: New Targeted Compounds for the Mitochondria

Haydeé Bastidas1, Gabriel Araya-Valdés1, Gonzalo Cortés1

  • 1Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Insights

Caffeic acid, a plant-derived polyphenol, shows potent anticancer effects by disrupting cancer cell metabolism and mitochondrial function. New derivatives targeting mitochondria offer promising therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Mitochondrial Biology
  • Natural Products Chemistry

Background:

  • Cancer's complexity necessitates novel therapeutic approaches, particularly those targeting cancer cell metabolism.
  • Mitochondrial dysfunction is a key strategy for inducing cancer cell death.
  • Polyphenols, like caffeic acid, are natural compounds with demonstrated antitumoral properties.

Approach:

  • This review examines the antitumoral capacity and mechanisms of action of caffeic acid and its derivatives.
  • Focus is placed on novel caffeic acid derivatives designed to target mitochondria.
  • These derivatives utilize chemical binding to lipophilic cations, such as triphenylphosphonium, for mitochondrial localization.

Key Points:

  • Caffeic acid exhibits significant antitumoral activity through various mechanisms.
  • Mitochondria are critical targets for cancer therapy, and disrupting their function leads to cancer cell death.
  • Novel caffeic acid derivatives are being developed to specifically target and disrupt mitochondrial function in cancer cells.

Conclusions:

  • Caffeic acid and its derivatives represent a promising class of compounds for cancer therapy.
  • Targeting mitochondrial function is an effective strategy for developing new anticancer drugs.
  • Further research into caffeic acid derivatives could lead to innovative cancer treatments.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K